Moving skin cancer treatment to GPs may be costly

Moving skin cancer treatment to general practice may result in an excess of benign excisions and result in being less efficient and less cost effective, a new study shows.

The Cork University Hospital study compared the benign and malignant ratio for specimens referred by general practice, general surgery and the skin cancer service to the regional pathology laboratory over one month.